These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9804058)

  • 21. Differential effects of talipexole and bromocriptine on serotonin release from rat intestinal tissues--an in vitro study of the emetic response of antiparkinsonian dopamine agonists.
    Minami M; Kohno Y; Endo T; Nemoto M; Ogawa T; Ihira E; Hamaue N; Hirafuji M
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):3-12. PubMed ID: 10604273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH
    Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
    Kitamura Y; Kosaka T; Kakimura JI; Matsuoka Y; Kohno Y; Nomura Y; Taniguchi T
    Mol Pharmacol; 1998 Dec; 54(6):1046-54. PubMed ID: 9855633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes.
    Hazell AS; Itzhak Y; Liu H; Norenberg MD
    J Neurochem; 1997 May; 68(5):2216-9. PubMed ID: 9109551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Clarke CE; Boyce S; Sambrook MA; Stahl SM; Crossman AR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):35-8. PubMed ID: 2907097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
    Gagnon C; Bédard PJ; Di Paolo T
    Eur J Pharmacol; 1990 Mar; 178(1):115-20. PubMed ID: 1970537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
    Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G; Morissette M; Parent M; Di Paolo T
    Eur J Neurosci; 2011 May; 33(10):1823-31. PubMed ID: 21501255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo.
    Ortiz GG; Crespo-López ME; Morán-Moguel C; García JJ; Reiter RJ; Acuña-Castroviejo D
    Neuro Endocrinol Lett; 2001 Apr; 22(2):101-8. PubMed ID: 11335886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease.
    Ono S; Hirai K; Tokuda E
    Biol Pharm Bull; 2009 Oct; 32(10):1813-7. PubMed ID: 19801850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
    Domae M; Yamada K; Hanabusa Y; Matsumoto S; Furukawa T
    Eur J Pharmacol; 1990 Apr; 179(1-2):75-82. PubMed ID: 2142088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
    Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Life Sci; 1991; 49(7):535-43. PubMed ID: 1677740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
    Zou L; Xu J; Jankovic J; He Y; Appel SH; Le W
    Neurosci Lett; 2000 Mar; 281(2-3):167-70. PubMed ID: 10704769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.